Peri-vascular Adipose Tissue Inflammation Evaluated Using Coronary CT Angiography

PHASE2RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

November 18, 2020

Primary Completion Date

January 31, 2024

Study Completion Date

January 31, 2024

Conditions
Cardiovascular Risk Factor
Interventions
DRUG

aspirin and atorvastatin

Patients will be randomized and prescribed either no treatment or aspirin 75mg and Atorvastatin 40mg

Trial Locations (3)

LE3 9QP

RECRUITING

University Hospitals of Leicester, Leicester

SW3 6NP

RECRUITING

Royal Brompton Hospitals Trust, London

OX3 9DU

RECRUITING

John Radcliffe Hospital, Oxford

All Listed Sponsors
collaborator

University of Oxford

OTHER

collaborator

British Heart Foundation

OTHER

collaborator

National Institute for Health Research, United Kingdom

OTHER_GOV

lead

University of Leicester

OTHER